We deliver innovative strategies and technology solutions for global life sciences companies across the entire product lifecycle, reducing time-to-market, accelerating research and drug discovery, and optimizing commercial operations to drive top-line growth.
Life Sciences
8/10
TOP PHARMA COMPANIES RELY ON EPAM
900+
SYSTEMS, APPLICATIONS & TOOLS DEVELOPED
AWARD WINNING SOLUTIONS
MedTech
We validate data-enriched business opportunities as well as design, develop and commercialize medical devices, solutions and systems that are compliant with regulatory and quality requirements.
WHAT WE DO
Next-Generation Clinical Trial Design
Data-Driven Clinical Innovation & Integration of Clinical Execution
Digital Supply Chain
R&D Acceleration & Genomics
Commercial Transformation
Medical/Surgical Device & Product Development
Informatics & Insight
Human-Centered Design
SolutionsHub
Explore our enterprise software products, open source solutions and accelerators for the life sciences industry featured on EPAM SolutionsHub.
WHO WE SERVE
Global Pharmaceutical & Biotech Companies
Scientific Instrumentation & Medical Device Companies
Animal & Agriculture Health Companies
Consumer Health
Retail Pharmacies
Life Sciences Software Vendors
HEAR FROM OUR CUSTOMERS
“Being able to deliver thoughtful, engaging customer experiences is a crucial factor for us in maintaining a strategic competitive advantage. EPAM’s ability to deliver our vision, in the form of an integrated platform with a single view of our customer, has led to a noticeable increase in request for quotes and individual customer spend, which we expect will translate to an increase in online transaction revenue. Our successful collaboration is a testament to our combined depth in innovation and customer-centric thinking.”
Chris Batten
Digital Customer Experience Leader, GE Healthcare Life Sciences
HEAR FROM OUR CUSTOMERS
“The exceptional collaboration between UCB and EPAM Life Sciences resulted in an innovative discovery platform known as AccelEpi that accelerates the detection process of epileptic seizures in rodent experiments.”
Dr. Rafal Kaminski
Head of Epilepsy, UCB
-
In the NewsAvoiding the Pervious Pitfalls of a Drug Launch
In this Biotechnology News article, EPAM’s George Litos and Ken Edwards explain how digital transformation can help mRNA companies overcome sales, marketing and supply chain challenges for a therapeutic launch.
-
In the NewsRPA: Recruiting Bots to Accelerate Clinical Trials
-
BlogVR Games: A New Diagnostic Standard for Testing Neurocognitive Decline
-
Blog
Making the Case for Smart Combination Drug Delivery Devices & Systems
-
In the NewsEPAM & Syngenta: Driving Excellence in R&D Technology & Beyond
EPAM’s solutions deliver stability, automation and infrastructural elasticity and scalability for Syngenta, a global agriscience company, to make data-driven decisions and build AI-powered workflows.
-
White PaperThe Quest for a New Framework: Life Sciences Sector
-
BlogLessons Learned in Commercializing mRNA Therapies
Want to talk to us about your digital needs?
We'd love to hear from you!